Catalyst Pharma Stock Price (NASDAQ:CPRX)

Add to My Stocks
$3.07 $0.03 (0.97%) CPRX stock closing price Sep 19, 2018 (Closing)
Prev Close* : $3.1
Market Cap:
$318.06M
Day Low: $3.05
52 Week Low: $2.18
Open: $3.11
Volume: -
Day High: $3.15
52 Week High: $4.51
Dividend:
0.00

Latest Stock Market News

Latest Articles

Catalyst Pharma News - From Partners

CPRX Stockcharts

View CPRX PE ratio, PS ratio stocks charts and compare with peers.
CPRX Chart
Note: Compare Catalyst Pharma stock price history with the index and industry peers.

Catalyst Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Catalyst Pharma Returns

ROE
(return on equity)

Catalyst Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

CPRX Industry Peers

Company Price Change (%)
Nutraceutical International (NUTR)41.80 (0%)
Assertio Therap (ASRT)5.960.07 (1.19%)
Pfizer (PFE)43.260.25 (0.57%)
Abbott (ABT)68.50.09 (0.13%)
Johnson & Johnson (JNJ)140.460.08 (0.06%)
Neurocrine Biosciences (NBIX)117.412.85 (2.37%)
Glaxosmithkline (GSK)39.550.08 (0.2%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Catalyst Pharmaceuticals Inc Stock News - Partner Headlines

Catalyst Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-18.41M-18.07M-20.23M-15.5M-12.15M
Total Operating Expense18.67M19.27M20.39M14.58M10.3M
View Catalyst Pharma income statement
balance sheet20172016201520142013
Total Assets85.38M41.7M60.1M43.9M25.36M
Total Liabilities4.42M2.39M4.62M8.66M3.97M
Shareholders Equity80.96M39.3M55.47M35.24M21.39M
View Catalyst Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities2.02M-0.88M---
Net Cash from (used by) Operating Activities-13.74M-17.96M-18.01M-12.94M-9.87M
Increase (Decrease) in Prop Plant And Equipment--0.09M-0.02M-0.05M-0.01M
View Catalyst Pharma cash flow statement

Catalyst Pharma Stock Message Board

As of last trading day, Catalyst Pharma stock price was $3.07. Catalyst Pharma market capitalization is $318.06M and it represents the total market value of CPRX stock. Catalyst Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The terms stocks and shares mean the same thing. For Ex: Catalyst Pharma stock price and Catalyst Pharma share price mean the same thing. 976,721 shares were traded with a closing stock price of $3.07 as of Sep 19, 2018, as can be seen from Catalyst Pharma stock quote. One can view Catalyst Pharma stock chart to follow the stock price trend. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Catalyst Pharma does not pay dividends. Catalyst Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.